The theory and practice of ovulation induction with gonadotropin-releasing hormone.

Abstract

Gonadotropin-releasing hormone therapy has undergone sufficient basic and clinical investigation as a tool for ovulation induction that it should now be considered a safe and effective infertility therapy for office practice. Nevertheless, there remains sufficient mystique about patient selection, optimal dosage and route of delivery, and apprehension on the part of both physicians and patients about cost and inconvenience of medication pumps that gonadotropin-releasing hormone therapy has not enjoyed the widespread acceptance it deserves. This article presents straightforward guidelines for therapy that are based on a detailed review of current literature, together with new information about evolving pump technologic characteristics, that should offer reassurance to the practitioner considering use of gonadotropin-releasing hormone therapy in her/his practice.

• Authors: R L Reid, R Fretts, D A Van Vugt
• Journal: American journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 158 Issue 1 Pg. 176-85 (Jan 1988) ISSN: 0002-9378 [Print] United States
• PMID: 3276198 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Pituitary Hormone-Releasing Hormones

Topics

• Female
• Humans
• Infertility, Female (therapy)
• Luteal Phase
• Ovulation Induction (methods)
• Pituitary Hormone-Releasing Hormones (administration & dosage, adverse effects, therapeutic use)
• Pregnancy